We have created the Tumor Board by leveraging many years of oncology experience. The Tumor Board meets frequently to assess, chart-by-chart, the special needs of current and prospective patients.
The CHIPSA Tumor Board (CTB) is a multidisciplinary think-tank of physicians and researchers who actively review the current extent of a patient’s disease, complications arising from the disease or prior treatments, and comorbidities (such as diabetes, coronary heart disease, cancer) that may affect future treatment options.
All appropriate specialties are considered and consulted in order to coordinate promising treatments.
With many cumulative years of oncology experience, the CTB meets frequently to assess, chart-by-chart, the special needs of current and prospective patients. Based on standard S.O.A.P (subjective data, objective data, assessment and plan), the impression and recommendations that result from the CTB conference create structured methodologies for each patient aimed at providing the best potential treatments in pursuit of the best possible outcomes.
Tumor Board Members
Dr. Anton Escobedo, MD - Medical Director
Dr. Pablo Fok, MD - Director of Surgery
Dr. Enrique Menes, MD - Director of Out Patient
Dr. Jesus Sanchez, MD ND - Surgical Oncologist
Gar Hildebrand - Epidemiologist
Dr. Brenda Lopez - Director of Aftercare
Dr. Mariela CT Touche, MD
Dr. Ana Orenday Hernandez, MD
Dr. Omar Pizano, MD
Dr. Montemayor, MD
Miriam Aguilar - Head Nurse
Sam Wagner - CEO of Batu Biologics
Scientific Advisory Board
Dr. Francesco Marincola - MD
Dr. Thomas Ichim, PhD. (Honorary Member)
Dr. Vijay Mahant, MS, PhD.
Dr. Phillip S. Kim PhD.